ProShare Advisors
KRRO icon

ProShare Advisors’s Korro Bio KRRO Stock Holding History

ProShare Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-237
Closed -$61K – 2256
2021
Q4 		$61K Buy
237
+8
+3% +$2.43K ﹤0.01% 2262
2021
Q3 		$81K Sell
229
-60
-21% -$23.6K ﹤0.01% 1934
2021
Q2 		$144K Buy
289
+61
+27% +$29.8K ﹤0.01% 2225
2021
Q1 		$108K Buy
228
+13
+6% +$25.3K ﹤0.01% 2156
2020
Q4 		$380K Buy
+215
New +$284K ﹤0.01% 1440

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

ProShare Advisors's KRRO Position: Q1 2022 in Review

ProShare Advisors sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 237 shares — an estimated $61K sold.

ProShare Advisors first reported a position in KRRO in Q4 2020 and held it in 5 quarters. The position peaked at $380K in Q4 2020. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • ProShare Advisors reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 237 Korro Bio shares in Q1 2022, an estimated $61K.
  • ProShare Advisors first reported a position in Korro Bio in Q4 2020 and held it in 5 quarters.
  • ProShare Advisors's Korro Bio position peaked at $380K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.